May 29, 2015 /

CAT-1004 (Catabasis) Clinical Trial Webinar (May 2015)

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

CAT-1004 (Catabasis) Clinical Trial Webinar [May 2015]

On May 13, 2015, Dr. Joanne Donovan, Chief Medical Officer at Catabasis Pharmaceuticals, presented information about MoveDMD: an upcoming Phase 1/2 clinical trial with CAT-1004 in boys with Duchenne muscular dystrophy.
Research & Clinical Trial Webinars,
Webinars

Join Our Mailing List

This field is for validation purposes and should be left unchanged.
BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo